Raybow was founded in 2008 as the CDMO division of Jiuzhou Pharmaceutical to provide expert process development and manufacturing for biotech and large pharma clients. Raybow can accommodate a variety of chemistries, including high potency,and offers high quality, efficient and cost-effective services designed to accelerate the drug development process. Raybow manufactures advanced intermediates, regulatory starting materials and active pharmaceutical ingredients in a US FDA inspected facility in Taizhou, China. Client projects cover all phases of development from pre-clinical to commercial.
Raybow Pharmaceutical, a global pharmaceutical chemistry services provider, has acquired US-based PharmAgra Labs. Nov 4, 2019 | Read Story